These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19833161)

  • 1. Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.
    Penner J; Rupsingh R; Smith M; Wells JL; Borrie MJ; Bartha R
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):104-10. PubMed ID: 19833161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.
    Bartha R; Smith M; Rupsingh R; Rylett J; Wells JL; Borrie MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):786-93. PubMed ID: 18252268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced hippocampal glutamate in Alzheimer disease.
    Rupsingh R; Borrie M; Smith M; Wells JL; Bartha R
    Neurobiol Aging; 2011 May; 32(5):802-10. PubMed ID: 19501936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of functional MRI markers in mild cognitive impairment.
    Zhang B; Li M; Sun ZZ; Zhu B; Yuan L; Wang Y; Xu Y
    J Clin Neurosci; 2009 May; 16(5):635-41. PubMed ID: 19264490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.
    Bokde AL; Karmann M; Teipel SJ; Born C; Lieb M; Reiser MF; Möller HJ; Hampel H
    J Clin Psychopharmacol; 2009 Apr; 29(2):147-56. PubMed ID: 19512976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
    Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
    Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.
    Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Zhang W; Zang FC
    Behav Brain Res; 2012 Nov; 235(1):1-6. PubMed ID: 22828014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.
    Mega MS; Dinov ID; Porter V; Chow G; Reback E; Davoodi P; O'Connor SM; Carter MF; Amezcua H; Cummings JL
    Arch Neurol; 2005 May; 62(5):721-8. PubMed ID: 15883258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
    Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on Alzheimer drugs (galantamine).
    Raskind MA
    Neurologist; 2003 Sep; 9(5):235-40. PubMed ID: 12971834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting.
    Aguglia E; Onor ML; Saina M; Maso E
    Curr Med Res Opin; 2004 Nov; 20(11):1747-52. PubMed ID: 15537474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nicotinic Receptor, galantamine and Alzheimer disease].
    Arroyo G; Aldea M; Fuentealba J; García AG
    Rev Neurol; 2002 Jun 1-15; 34(11):1057-65. PubMed ID: 12134305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR spectroscopic evaluation of brain tissue damage after treatment for pediatric brain tumors.
    Blamek S; Larysz D; Ficek K; Sokół M; Miszczyk L; Tarnawski R
    Acta Neurochir Suppl; 2010; 106():183-6. PubMed ID: 19812945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-H MRS changes in dorsolateral prefrontal cortex after donepezil treatment in patients with mild to moderate Alzheimer's disease.
    Henigsberg N; Kalember P; Hrabać P; Rados M; Bajs M; Rados M; Kovavić Z; Loncar M; Madzar T
    Coll Antropol; 2011 Jan; 35 Suppl 1():159-62. PubMed ID: 21648328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.